Ray Dalio's position in Regeneron Pharmaceuticals is currently worth $98.1 Million. That's 0.53% of their equity portfolio (41st largest holding). The first Regeneron Pharmaceuticals trade was made in Q2 2013. Since then Ray Dalio bought shares sixteen more times and sold shares on fifteen occasions. The stake costed the investor $79.5 Million, netting the investor a gain of 23% so far.